Down-regulation of BRMS1 mRNA expression in breast cancer is not related to the presence of axillary node metastasis

Cancer Genomics and Proteomics

Volumn 2, Issue 3, 2005, Pages 145-149

  Gomez Esquer F ^a   Agudo, D ^a   Martinez Arribas F ^b   Diaz Gil G ^a   Pollan M ^c   Schneider, J ^a,b  

^a UNIVERSIDAD REY JUAN CARLOS   (Spain)

^b Centro de Patología de la Mama Fundación Tejerina   (Spain)

^c CARLOS III INSTITUTE OF HEALTH   (Spain)

Author keywords

Breast; BRMS1; Cancer; Metastasis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; GENE PRODUCT; HORMONE RECEPTOR; KI 67 ANTIGEN; MAMMAGLOBIN; MESSENGER RNA; NUCLEOPORIN; NUCLEOPORIN 88; PROTEIN BRMS1; PROTEIN P53; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; AXILLARY LYMPH NODE; BREAST CARCINOMA; BRMS1 GENE; CELL NUCLEUS; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PLOIDY; PROTEIN EXPRESSION; TUMOR SUPPRESSOR GENE;

EID: 20344389517     PISSN: 11096535     EISSN: 17906245     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Seraj MJ, Samant RS, Verderame MF and Welch DR: Functional evidence for a novel human breast carcinoma metastasis suppressor, BRMS1, encoded at chromosome 1q13. Cancer Res 60: 2764-9, 2000.
2. Shevde LA, Samant RS, Goldberg SF, Sikaneta T, Alessandrini A, Donahue HJ, Maujer DT and Welch DR: Suppression of human melanoma by the metastasis suppressor gene, BRMS1. Exp Cell Res 273: 229-39, 2002.
3. Núñez-Villar MJ, Martínez-Arribas F, Pollán M, Lucas AR, Sanchez J, Tejerina A and Schneider J: Elevated mammaglobin (h-MAM) expression in breast cancer is associated with clinical and biological features defining a less aggressive tumor phenotype. Breast Cancer Res 5: R65-R70, 2003.
4. Agudo D, Gómez-Esquer F, Martínez-Arribas F, Núñez-Villar MJ, Pollán M and Schneider J: Nup88-mRNA overexpression is associated with high aggressiveness of breast cancer. Int J Cancer 709: 717-20, 2004.
5. Schneider J, Pollán M, Jiménez E, Marenbach K, Martínez N, Volm M, Marx D and Meden H: Nm23-H1 expression defines a high-risk subpopulation of patients with early-stage ovarian carcinoma. Br J Cancer 82: 1662-70, 2000.
6. Srinivas P, Madhavan M, Ahamed I, Abraham E, Vijayalakshmy NR and Balaram P: Nm23H1 and p53 proteins are differently correlated to metastasis in breast carcinoma. Neoplasma 49: 225-30, 2002.
7. Belev B, Aleric I, Vrbanec D, Petrovecki M, Unusic J, Jakic-Razumovic J: Nm23 gene product expression in invasive breast cancer-immunohistochemical analysis and clinicopathological correlation. Acta Oncol 41: 355-61, 2002.
8. Leone A, Flatow U, Van Houtte K and Steeg P: Transfection of human Nm23 into human MDA-MB-435 breast carcinoma cell line: effects on tumor metastatic potential, colonization and enzymatic activity. Oncogene 8: 2325-33, 1993.